Reducing Risk And Improving Synthesis Outcomes In Drug Discovery
Source: MilliporeSigma

Chemical synthesis is not just tricky – it’s risky.
From supply chain shortages to regulatory restrictions to safety considerations–reducing risk is a top priority.
SYNTHIA™ Retrosynthesis Software reduces risk by identifying multiple, shorter, more robust pathways, which saves time and reduces costs.
Using expert-coded rules and advanced algorithms powered by AI developed over 15 years, this decision support tool has become the strategic partner of organic chemists in laboratories across pharma, biotechnology, chemical industry and academia.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more